๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Dachengqi Decoction for Enhancing Early Gastrointestinal Recovery After Whipple Surgery
NCT06948474Whipple Operation
China-Japan Friendship Hospital
Not applicable
45
Beijing
2024-08-01
Recruiting
Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
NCT07251868Breast Cancer, Brain Metastases From Breast Cancer, Trop2
DrugSacituzumab Govitecan
Peking University Cancer Hospital & Institute
Observational
100
Beijing
2024-08-01
Recruiting
Effect of the Postbiotics on Complications Treatment in Elderly Hemodialysis Patients
NCT06975995Hemodialysis Complication
Peking University First Hospital
Not applicable
60
Beijing
2024-08-01
Recruiting
An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.
NCT07101237Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (ICC), Primary Liver Cancer
Peking Union Medical College Hospital
Observational
308
Beijing
2024-08-01
Recruiting
Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients
NCT07632664Lung Neoplasm, Thoracic Surgical Procedures, Perioperative Care, Postoperative Rehabilitation
Peking University People's Hospital
Not applicable
1,000
Beijing
2024-08-01
Recruiting
Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)
NCT06429774Traumatic Brain Injury
Beijing Tiantan Hospital
Observational
2,000
Beijing, Baoding, Cangzhou, Chengde, Handan, Langfang, Qinhuangdao, Shijiazhuang
2024-08-01
Recruiting
The Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet-rich Plasma for the Trigeminal Neuralgia
NCT06472323Trigeminal Neuralgia, Idiopathic, PRP
Beijing Tiantan Hospital
Observational
270
Beijing
2024-08-01
Recruiting
Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
NCT06550921Advanced Hepatocellular Carcinoma, Oligometastasis, Ablation, Anti-PD1 Antibody
Sun Yat-sen University
Not applicable
60
Beijing
2024-08-01
Recruiting
Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease
NCT06874803Parkinson's Disease (PD)
Jiani Wu
Not applicable
60
Beijing
2024-08-01
Recruiting
Opioid Free Anesthesia on the Quality of Early Recovery
NCT05577962Opioid-free Anesthesia
Beijing Friendship Hospital
Phase 4
160
Beijing
2024-08-01
Recruiting
Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)
NCT07119021Ischemic Stroke
DrugEdaravone
Ruijun Ji
Phase 4
300
Beijing
2024-08-01
Not yet open
Implementation Research on the Intervention Mode of " Comorbidity-Co-causes-Joint-prevention" Comprehensive Demonstration District of Depression and Obesity Among Children and Adolescents in Beijing
NCT06489990Depression, Obesity, High Risk of Depression, Overweight
Capital Medical University
Not applicable
440
Beijing
2024-08-01
Recruiting
Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal
NCT06707129Non-alcoholic Fatty Liver Disease
Beijing Municipal Administration of Hospitals
Observational
50
Beijing
2024-08-01
Recruiting
Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon
NCT06696664Chronic Hepatitis B
DrugPEG-IFNฮฑ
Minghui Li
Observational
120
Beijing
2024-08-01
Recruiting
Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT
NCT07660406Keloid
Peking Union Medical College Hospital
Phase 1/2
30
Beijing
2024-08-01
Recruiting
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
NCT05387031Crohn Disease, Stricture; Bowel, Intestinal Stricture
DrugUstekinumab
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
239
Beijing, Chongqing, Guangzhou, Huai'an, Suzhou, Yangzhou, Hangzhou
2024-08-01
Not yet open
Antiviral Therapy in Infants With HBV Infection
NCT06503796HBV
DrugsLamivudine·Interferon
Beijing 302 Hospital
Phase 4
60
Beijing
2024-08
Not yet open
A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage โ…ก-โ…ข Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive
NCT06524518DFS
Xuanwu Hospital, Beijing
Phase 2
213
Beijing
2024-08
Recruiting
CPVI With Modified Linear Ablation Versus CPVI in Patients With Long-standing Persistent Atrial Fibrillation (SINUS)
NCT06516822Long-standing Persistent Atrial Fibrillation, Ablation
The First Affiliated Hospital with Nanjing Medical University
Not applicable
320
Beijing, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Dalian, Jinan, Xiโ€™an
2024-07-31
Active, closed
SAVE-PCI: NyokAssistโ„ข Small-Bore VAD vs. IABP in Elective High-Risk PCI
NCT07010965High-Risk PCI
magAssist, Inc.
Not applicable
236
Beijing, Changsha, Guangzhou, Hangzhou, Harbin, Lanzhou, Shanghai, Taiyuan
2024-07-31
Recruiting
A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
NCT06470191Primary Membranous Nephropathy
DrugB007
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2/3
216
Beijing, Changchun, Guangzhou, Hangzhou, Jinan, Nanning, Nantong, Qingdao
2024-07-30
Not yet open
Electroacupuncture Treatment of Behavioral and Psycological Symptoms in Patients With Alzheimer's Disease
NCT06523309BPSD (Behavioral and Psycological Symptoms of Dementia), Alzheimer's Dementia
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Observational
1,000
Beijing, Fuzhou, Harbin
2024-07-30
Recruiting
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
NCT06519760Carbonic Anhydrase IX, PET-CT, Clear Cell Renal Cell Carcinoma
Peking University First Hospital
Not applicable
200
Beijing
2024-07-30
Recruiting
Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients
NCT06423547Postoperative Delirium, Postoperative Neurocognitive Disorder, Surgery
Xuanwu Hospital, Beijing
Observational
10,000
Beijing
2024-07-30
Recruiting
IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)
NCT06513429Refractory Systemic Lupus Erythematosus
Peking University Third Hospital
Not applicable
6
Beijing
2024-07-30
By invitation
Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis
NCT06629623Idiopathic Pulmonary Fibrosis
Chu Hongling
Observational
310
Beijing
2024-07-30
Recruiting
A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
NCT06505395Gastrointestinal Neuroendocrine Pancreatic Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2
90
Beijing
2024-07-30
Recruiting
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
NCT06512051Advanced or Metastatic Non-small Cell Lung Cancer
DrugsSHR-A2102·Adebrelimab·Bevacizumab·Cisplatin
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
248
Beijing
2024-07-30
Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer
NCT07356531Liver Cancer
JIANGSU SHENMING Medical Technology CO., Ltd
Not applicable
216
Hefei, Beijing, Nanning, Guiyang, Shijiazhuang, Anyang, Luoyang, Zhengzhou
2024-07-29
Recruiting
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
NCT06083207Multiple Myeloma
DrugIBI3003
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
116
Beijing, Nanning, Wuhan, Nanjing, Suzhou, Xuzhou, Nanchang, Shanghai
2024-07-29
Recruiting
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
NCT06386146Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
144
Beijing, Guangzhou, Zhengzhou, Shenyang, Jinan, Shanghai
2024-07-24
Active, closed
Accuracy, Stability and Safety of Orthodontic Mini-implant Template in the Infrazygomatic Crest Zone
NCT06786221Dental Implants, Dental Implantation
Universiti Sains Malaysia
Not applicable
24
Beijing
2024-07-24
Active, closed
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
NCT06459180Cervical Cancer
DrugsTisotumab Vedotin·Vinorelbine·Topotecan·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
686
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Zhanjiang, Nanning
2024-07-24
Recruiting
A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors
NCT07093970Advanced Solid Tumors
DrugMRG006A
Lepu Biopharma Co., Ltd.
Phase 1/2
343
Beijing, Shanghai
2024-07-24
Recruiting
PulseSelectโ„ข PFA Global Registry
NCT06393920Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
1,950
Beijing, Fuzhou, Harbin, Kunming, Nanjing, Shanghai, Shenzhen, รœrรผmqi
2024-07-23
Recruiting
Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency
NCT06481969Premature Ovarian Insufficiency
Rui Yang
Not applicable
260
Beijing
2024-07-23
Recruiting
Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
NCT06351150Vasodilatory Shock
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
214
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Qingyuan
2024-07-23
Recruiting
A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients.
NCT06512116Advanced Solid Tumor
Shanghai Institute Of Biological Products
Phase 1
196
Beijing
2024-07-23
Recruiting
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
NCT06431490Biliary Tract Cancer
DrugTQB2102
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1/2
102
Fuyang, Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Jiangmen
2024-07-22
Active, closed
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
NCT06347003Severe Hypertriglyceridemia
DrugPlozasiran
Arrowhead Pharmaceuticals
Phase 3
446
Bengbu, Beijing, Guangzhou, Guanzhou, Liuzhou, Xingtai, Luoyang, Wuhan
2024-07-22
Recruiting
Effect of Early Gait Training on Knee Cartilage Degeneration After Anterior Cruciate Ligament Reconstruction
NCT06368544Anterior Cruciate Ligament Injuries, Cartilage Degeneration
Peking University Third Hospital
Not applicable
60
Beijing
2024-07-22
Recruiting
Electroacupuncture for Dysmenorrhea Secondary to Adenomyosis
NCT06364592Dysmenorrhea, Adenomyosis, Electroacupuncture
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
30
Beijing
2024-07-21
Not yet open
Electroacupuncture for the Treatment of Agitated Symptoms of Alzheimer's Disease
NCT06495957Agitation Associated With Alzheimer's Dementia, Alzheimer's Dementia
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
224
Beijing, Fuzhou, Harbin
2024-07-20
Recruiting
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
NCT06282575Biliary Tract Cancer
DrugsZanidatamab·Durvalumab·Gemcitabine·Cisplatin
Jazz Pharmaceuticals
Phase 3
286
Hefei, Beijing, Lanzhou, Harbin, Changsha, Changchun, Jinan, Chengdu
2024-07-19
Recruiting
A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors
NCT06553339Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma
DrugHS-10516
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
60
Beijing
2024-07-19
Recruiting
Digital Therapy in Self-management of COPD Patients
NCT06776601Chronic Obstructive Pulmonary Disease
China-Japan Friendship Hospital
Not applicable
600
Beijing
2024-07-18
Recruiting
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
NCT06536959Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes, Minimal Residual Disease
Beijing 302 Hospital
Phase 2
67
Beijing
2024-07-18
Active, closed
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
NCT06257966Type2 Diabetes Mellitus
DrugsExendin-4 Fc fusion protein·Dulaglutide·Metformin
Beijing Dongfang Biotech Co., Ltd.
Phase 3
600
Beijing
2024-07-17
Recruiting
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
NCT06413654Neuromyelitis Optica Spectrum Disorders
DrugB001
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2/3
132
Beijing, Cangzhou, Changsha, Chengdu, Fuzhou, Guangzhou, Guiyang, Hangzhou
2024-07-17
Recruiting
A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.
NCT06434597Biliary Tract or Colorectal Cancer With Her2-positive/Mutated
DrugSPH5030
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2
60
Beijing, Changsha, Changzhi, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei
2024-07-17
Recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
NCT06456580Generalized Myasthenia Gravis
DrugTelitacicept
Vor Biopharma
Phase 3
180
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Zunyi, Wuhan
2024-07-17
Recruiting
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
NCT06504290Schizophrenia
DrugVV119
Vigonvita Life Sciences
Phase 1
40
Beijing, Xiโ€™an
2024-07-16
Recruiting
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226Orbital Neoplasms
Peking University Third Hospital
Not applicable
50
Beijing
2024-07-16
Active, closed
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
NCT06456346Essential Thrombocythemia
DrugsBomedemstat·Hydroxyurea
Merck Sharp & Dohme LLC
Phase 3
300
Bengbu, Hefei, Beijing, Chongqing, Quanzhou, Xiamen, Guangzhou, Shijiazhuang
2024-07-16
Recruiting
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
NCT06453902Chronic Myeloid Leukemia, Accelerated Phase CML
DrugTGRX-678
Shenzhen TargetRx Co., Ltd.
Phase 2
40
Beijing
2024-07-15
Active, closed
Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver Injury
NCT06547229Recurrent Drug-induced Liver Injury
Beijing Friendship Hospital
Observational
60
Beijing
2024-07-15
Not yet open
Prospective Observational Cohort Study
NCT06493448Gastric Cancer, Liver Metastases
Lin Chen
Observational
1,326
Beijing
2024-07-15
Recruiting
Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations
NCT06674343Advanced or Metastatic Non-small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 3
144
Beijing
2024-07-15
Recruiting
Modified Aortic Root Enlargement Procedure
NCT06517537Small Aortic Annulus, Aortic Root Enlargement Procedure
China National Center for Cardiovascular Diseases
Observational
64
Beijing
2024-07-15
By invitation
Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage
NCT06519617Primary Sjรถgren Syndrome
DrugHydroxychloroquine Sulfate
Qingwen Tao
Phase 2
136
Beijing
2024-07-13
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanchang
2024-07-12
Recruiting
A Clinical Study of B007 in the Treatment of Pemphigus.
NCT06454357Pemphigus
DrugB007
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2/3
132
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Jinan, Shanghai
2024-07-12
Recruiting
Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive Lymphoma: A Multicenter Study
NCT07657494Aggressive Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
94
Beijing
2024-07-11
Recruiting
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
NCT06434610Platinum-resistant Recurrent Ovarian Cancer
DrugPaclitaxel
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2
90
Beijing, Bengbu, Changsha, Fuzhou, Guangzhou, Jinan, Kunming, Nanning
2024-07-11
Recruiting
A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
NCT06383767Metastatic Breast Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3
378
Beijing
2024-07-11
Recruiting
Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma
NCT06471738Ann Arbor Stage II Follicular Lymphoma, Grade 1 Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma
DrugsZanubrutinib·Venetoclax·Rituximab
Chinese PLA General Hospital
Phase 2
30
Beijing
2024-07-10
Recruiting
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
NCT06420076T Cell Lymphoma, T Cell Leukemia, T-cell Acute Lymphoblastic Leukemia, T-Cell Lymphoma of CNS
Essen Biotech
Phase 1/2
60
Beijing
2024-07-10
Active, closed
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
NCT06254014Type 2 Diabetes Mellitus
DrugExendin-4 Fc fusion protein
Beijing Dongfang Biotech Co., Ltd.
Phase 3
270
Beijing
2024-07-10
Recruiting
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
NCT06350110Systemic Lupus Erythematosus, Lupus Nephritis, Autoimmune Diseases, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Essen Biotech
Phase 1/2
75
Beijing
2024-07-10
Recruiting
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
NCT06213636Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin Lymphoma, B-cell, Diffuse Large B Cell Lymphoma
Essen Biotech
Phase 1/2
75
Beijing
2024-07-10
Recruiting
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
NCT06420063AML, Acute Myeloid Leukemia, AML, Adult Recurrent, AML, Adult
Essen Biotech
Phase 1/2
85
Beijing
2024-07-10
Recruiting
A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
NCT06500676KRAS G12D Mutations, Advanced Solid Tumors
DrugCetuximab
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
407
Hefei, Beijing, Guangzhou, Nanning, Haerbin, Zhengzhou, Wuhan, Changsha
2024-07-09
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
DrugIvosidenib
Servier Bio-Innovation LLC
Phase 3
136
Guangzhou, Wuhan, Shang'ai, Shanghai, Chengdu, Hangzhou, Beijing
2024-07-09
Active, closed
Efficacy and Safety of Colchicine After PCI
NCT06472908Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine
DrugColchicine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
8,862
Hefei, Beijing, Chongqing, Xiamen, Lanzhou, Harbin, Zhengzhou, Enshi
2024-07-09
Recruiting
Association Between Local Cerebral Oxygenation Monitoring and Postoperative Stroke in Carotid Endarterectomy
NCT06406842Carotid Endarterectomy, Cerebral Autoregulation
Beijing Tiantan Hospital
Not applicable
560
Beijing
2024-07-08
Recruiting
Investigating the Functional Characteristics During Wakefulness and Sleep Based on SEEG
NCT06524479Refractory Epilepsy, Sleep
Xuanwu Hospital, Beijing
Not applicable
20
Beijing
2024-07-08
Recruiting
Natural History of Coronary Atherosclerosis
NCT06040073Coronary Artery Disease Progression, Radial Wall Strain, Atherosclerotic Lesion, Optical Coherence Tomography
China National Center for Cardiovascular Diseases
Observational
125
Beijing
2024-07-07
Active, closed
Paired Emotion Reading Improves Emotion Regulation in Rural Children With ACE
NCT06505629Emotion Regulation, Adverse Childhood Experience
Peking University
Not applicable
150
Beijing
2024-07-06
Active, closed
A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy.
NCT06392724Duchenne Muscular Dystrophy (DMD)
Peking Union Medical College Hospital
Phase EARLY_PHASE1
3
Beijing
2024-07-05
Active, closed
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease
NCT06462469Steroid-refractory Acute Graft Versus Host Disease
DrugRuxolitinib
Novartis Pharmaceuticals
Phase 4
36
Guangzhou, Zhengzhou, Wuhan, Xian, Hangzhou, Beijing, Taian, Tianjin
2024-07-04
Recruiting
Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine
NCT06528197Primary Sjรถgren Syndrome
China-Japan Friendship Hospital
Observational
1,000
Beijing
2024-07-04
Recruiting
ARTEMIS-008๏ผšHS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
NCT06498479Small Cell Lung Cancer
DrugsHS-20093·Topotecan
Hansoh BioMedical R&D Company
Phase 3
460
Beijing, Harbin, Zhengzhou, Changchun, Shenyang, Jinan, Shanghai, Guangzhou
2024-07-04
Recruiting
Effects of Different Inhaled Oxygen Concentrations on Lung Function in Older Patients After Laparoscopic Gastrointestinal Surgery Under General Anesthesia
NCT06359106Oxygenation Index
China Medical University, China
Phase 4
1,176
Shenyang, Beijing, Chendu, Chifeng, Dalian, Harbin, Jinan, Kunming
2024-07-02
Recruiting
Goal Setting and Mobile-based Self-management Tool to Improve Diet Quality of People With High Blood Pressure
NCT06988501Blood Pressure, High
China National Center for Cardiovascular Diseases
Not applicable
110
Beijing
2024-07-02
Recruiting
Analyse of Inflammatory Activity of Sjรถgren's Syndrome on 68Ga-FAPI PET-CT
NCT07062523Sjogren's Syndrome
Drug68Ga-FAPI
Peking Union Medical College Hospital
Phase 1/2
60
Beijing
2024-07-01
Not yet open
LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma
NCT06472479Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University
Not applicable
66
Hefei, Zhengzhou, Nanjing, Beijing
2024-07-01
By invitation
EGPSS for Weight Management in an in Vivo Human Model
NCT07186959Obesity, Mild
Liu Yan
Not applicable
15
Beijing
2024-07-01
Recruiting
Study on the Trans-Carotid Artery Occlusion Shunt System Combined With Introducer Sets
NCT06959628Carotid Artery Stenosis, Carotid Artery Diseases
Shenzhen Wecan Medical Technology Co.,Ltd
Not applicable
15
Beijing
2024-07-01
Active, closed
Preserving the Pre-cardial Fat Pad During Sleeve Gastrectomy on Postoperative Gastroesophageal Reflux
NCT06732661Sleeve Gastrectomy, Pre-cardial Fat Pad, Excessive Weight Loss, Total Weight Loss
Beijing Chao Yang Hospital
Not applicable
50
Beijing
2024-07-01
Recruiting
Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
NCT06482645Prostate Cancer
Peking University First Hospital
Not applicable
640
Beijing
2024-07-01
Recruiting
The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
NCT06390306Chronic Myeloid Leukemia
DrugsPonatinib·Olverembatinib·Azacitidine·Venetoclax
Peking University People's Hospital
Observational
30
Beijing, Chengdu, Guangdong, Kunming, Nanjing, Nanning, Nanyang, Ningbo
2024-07-01
Active, closed
Effect of Glycosuria on Urinary Protein in Patients With Chronic Kidney Disease Treated With SGLT2 Inhibitors
NCT07084038Chronic Kidney Disease
Yuanjun Yang
Observational
300
Beijing
2024-07-01
Recruiting
Mechanism and Application of DBS in the Treatment of PD
NCT06400017Parkinson's Disease and Parkinsonism
Beijing Tiantan Hospital
Not applicable
60
Beijing
2024-07-01
Recruiting
Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO
NCT06276010Extracorporeal Membrane Oxygenation Complication
Xiaotong Hou
Not applicable
80
Beijing
2024-07-01
Recruiting
Second Haplo-transplantation for Graft Failure
NCT06512519Graft Failure, Stem Cell Transplant Complications
Peking University People's Hospital
Not applicable
34
Beijing
2024-07-01
Recruiting
The Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet-rich Plasma for Infraorbital Neuralgia
NCT06492213Infraorbital Neuralgia, Platelet-rich Plasma
Beijing Tiantan Hospital
Observational
240
Beijing
2024-07-01
Recruiting
Modified Second Haplo-transplantation for Graft Failure
NCT06512545Graft Failure, Stem Cell Transplant Complications
Peking University People's Hospital
Not applicable
12
Beijing
2024-07-01
Not yet open
Catheter Ablation of Haemodynamically Not-tolerated Electrical Storm in Structural Heart Disease
NCT06455020Ventricular Tachycardia
Beijing Anzhen Hospital
Not applicable
96
Beijing, Changsha, Kunming, Nanjing
2024-07-01
Recruiting
Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)
NCT06195267Aortic Dissection, Systemic Inflammatory Response Syndrome, Cardiovascular Diseases (CVD)
Nanjing Medical University
Not applicable
500
Beijing, Nanjing
2024-07-01
Recruiting
The Safety and Performence of ShockPulse-10 in Patients with Coronary Artery Calcification
NCT06711822Coronary Arterial Disease (CAD), Calcification; Heart
Keya Medical
Not applicable
205
Beijing
2024-07-01
Rows per page Showing 3301–3400 of 5484
Previous 32 33 34 35 36 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=34

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.